| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |